Navigation Links
Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
Date:11/13/2008

t of traumatic acute spinal cord injury (SCI) by the European Commission. The European Commission's decision was adopted following the favorable opinion issued by the European Medicine Agency (EMEA) Committee of Orphan Medicinal Products (COMP) at their meeting on June 10 and 11, 2008.

-- Results of a preclinical study of ALSE-100 demonstrated that Rho inhibitors could be useful in promoting bone healing. The data were presented at the Australian and New Zealand Bone and Mineral Society Annual Meeting, August 28-30, 2008, in Melbourne, Australia.

-- A poster entitled: "Altropane(R) SPECT in Parkinson Disease patients and healthy controls" was presented at the 2nd International Symposium on Neuroimaging in Parkinson's Disease and Related Disorders, October 21-22, 2008, in Chatham, MA.

-- We amended the Option Agreement with BioAxone to extend the date by which we can exercise our option from October 27, 2008 to November 27, 2008.

Financial Highlights of the Third Quarter 2008

-- Cash, cash equivalents and marketable securities at September 30, 2008 totaled $1.3 million as compared to $4.2 million at December 31, 2007. Convertible notes payable totaled $33.3 million at September 30, 2008 as compared to $23.3 million at December 31, 2007.

-- Net loss attributable to common stockholders was $5.1 million, or $0.25 per share, for the third quarter of 2008, as compared to $4.7 million, or $0.23 per share, in the third quarter of 2007.

-- Research and development (R&D) expenses totaled $2.8 million in the third quarter of 2008 as compared to $2.5 million in the third quarter of 2007. The increase in R&D expenses was primarily due to higher Altropane clinical costs.

-- General and administrative (G&A) expenses totaled $1.7 million for the third quarter of 2008 as compared to $2.0 million in the third quarter of 2007. The decrease in G&A expenses was primarily related to lower legal, patent and consulting costs.

-
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Raises $5 Million
2. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
3. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
4. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
5. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
6. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
7. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
8. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
9. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
10. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
11. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... antibodies, announced today that the National Institutes of Health (NIH) has awarded the ... be administered by the NIH’s National Institute of Diabetes and Digestive and Kidney ...
(Date:9/1/2015)... The Dohmen Company today announced the ... as Chief Science Officer (CSO) of Dohmen Life ... Dr. Floyd will lead Dohmen,s growing regulatory consulting ... and post approval outsourced services in quality, regulatory, ... Floyd brings decades of experience leading global regulatory ...
(Date:9/1/2015)... ... September 01, 2015 , ... Knowledgent , the data and analytics ... advanced analytics utilizing data lakes in the healthcare industry. , As the Internet of ... of data over the last few years as more entities become technology enabled through ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... new Director of Business Development, Asia Pacific. In this newly-created position, Gibbs will ... awareness and use of iLab’s suite of tools. This entails not only introducing ...
Breaking Biology Technology:AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3
... 10 Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a ... today,announced that it will present at two investor conferences ... Investor Summit to be held at the,Mark Hopkins InterContinental ... 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time); and, ...
... 10 SoluBest Ltd., a privately,held, clinical stage ... Sheckler, MBA, as CEO. Mr. Sheckler brings over ... http://www.newscom.com/cgi-bin/prnh/20080910/NEW068LOGO ), Mr. Sheckler began ... selling nutritional and pharmaceutical products. During his,time there, ...
... Masimo (Nasdaq:,MASI), the inventor of Pulse ... customers purchasing the Masimo Radical-7, the company,s ... Alarm as a standard feature., Conventional ... and,isolated drops in oxygen saturation values, known ...
Cached Biology Technology:Halozyme Therapeutics to Present at Upcoming Investor Conferences 2SoluBest Appoints Michael Sheckler, MBA, as CEO 2Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices 2Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices 3
(Date:8/19/2015)... N.Y. , Aug. 19, 2015  VOXX ... that it has entered into a Definitive Agreement ... property, of iris authentication market leader EyeLock through ... VOXX will have a controlling interest in the ... subject to completion of due diligence.  Expanding on ...
(Date:8/12/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is proud to announce that iMedNet ... technology platform, has led the way to significant and ... 2015.   Q2 2015 and Q1 2015 were, respectively, ... value sold in the company,s 15 year history.  In ...
(Date:8/11/2015)... GOTHENBURG, Sweden , August 11, 2015 ... sensor FPC1155. Already received as well as expected revenues in 2015 ... included in FPC,s communicated revenue guidance of approximately 2,200 MSEK for ... is a prominent smartphone manufacturer ... ZUK selected FPC1 155 ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... life. It drives everything from photosynthesis to growth and ... light signals to control gene activity and ultimately a ... team of researchers from the Salk Institute for Biological ... gives the signal to revamp the plant,s gene expression ...
... For almost three decades, oceanographers have been puzzled by the ... there is very little nitrate, an essential algal nutrient. In ... Ken Johnson, along with coauthors Stephen Riser at the University ... show that mid-ocean algae obtain nitrate from deep water, as ...
... is part of a research team that has discovered ... giving chemists an important new tool in developing materials ... research, which is reported in the June 25 edition ... Dreyfus Professor of Chemistry at the Massachusetts Institute of ...
Cached Biology News:Connecting the dots: How light receptors get their message across 2Connecting the dots: How light receptors get their message across 3Researchers discover source of essential nutrients for mid-ocean algae 2Researchers discover source of essential nutrients for mid-ocean algae 3UD prof helps discover new chemical method important to drug design, agrichemicals 2UD prof helps discover new chemical method important to drug design, agrichemicals 3
... System is ideal for developing single ... reagents. The Luminex 100 Instrument System ... version 1.7, the XY platform and ... $2000 in free Beadlyte products if ...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Madin-Darby bovine kidney (MDBK) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: